FdaApplication
NDA 213978
Identifiers
- fda_app_no: NDA213978
Properties
| Property | Value |
|---|---|
| applicant_name | OYSTER POINT PHARMA INC |
| application_type | NDA |
| approval_date | 2021-10-15 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TYRVAYA | VARENICLINE TARTRATE | EQ 0.03MG BASE/SPRAY | SPRAY;NASAL |
1 product